Archive by date | September 2012

Updated – Transgenic cassava armed with dual disease resistance

George Osodi/Bloomberg via Getty Images

Long a food staple in Africa, the humble cassava may be poised to grow even further in significance as other crops like maize wither in the heat and drought of a warming climate. But agricultural scientists know that the hardy tuber has an Achilles Heel — disease — that could curb its future potential.  Read more

Conservationists to highlight successes with species ‘green list’

For years the ‘Red List’ of endangered species has told a tale of woe, as new species are ranked as endangered or threatened every year, and few show any improvement. Now the organisation behind the list of species and their conservation status is to set up a counterpoint ‘Green List’ to highlight conservation success.  Read more

Looming cutbacks threaten long-term US research

Sweeping US budget cuts set to begin in 2013 would reduce federal research and development funds by $57.5 billion over the next five years, according to a report released on 27 September by the American Association for the Advancement of Science (AAAS) based in Washington, DC.  Read more

FDA to oversee reporting of clinical trials

 The U.S. Federal Drug Administration is now charged with making sure companies submit all required data for clinical trials of drugs and medical devices. In a notice published today in the Federal Register, the Secretary of Health and Human services delegated its monitoring authority to the FDA.   … Read more

Newest NIH centre launches clinical trial

Researchers at the US National Institutes of Health are beginning a clinical trial for a rare, degenerative muscle disease. This is the first trial to start under the official endorsement of the National Center for Advancing Translational Sciences (NCATS) and was announced this week just as the first permanent head assumed leadership of the NIH’s newest institute. (See NIH insider will head translational medicine centre)   … Read more